Sahajanand Medical Technologies IPO Day 1: Subscription Opens Today, 15 October 2026

Sahajanand Medical IPO opens today, 15 Oct 2026, closes 19 Oct. Price band Rs 327-344. Lot size 43 shares. Lists on BSE and NSE on 23 Oct.

Updated: 15 Oct 2026 • 1:30 am

Posted by:

Quick Answer

The Sahajanand Medical Technologies IPO opens for subscription today, 15 October 2026, and will remain open until 19 October 2026. Sahajanand Medical Technologies Limited is a Surat-based medical devices maker, and the issue of about Rs 475.48 crore is entirely an offer for sale of up to 1,38,22,116 shares, so the company receives no proceeds. The price band is set at Rs 327 to Rs 344 per share, with a lot size of 43 shares, and the shares are proposed to list on BSE and NSE. Since bidding has only just opened, subscription figures will start reflecting real demand as the days progress, so investors should track the live numbers through the session before deciding.

Sahajanand Medical Technologies Limited, a Surat-based medical devices company incorporated in 2001, has opened its IPO for subscription today, 15 October 2026. The Sahajanand Medical Technologies IPO is a mainboard, book built issue worth about Rs 475.48 crore, made up entirely of an offer for sale of up to 1,38,22,116 equity shares, and it will remain open until 19 October 2026. Since the issue is a pure offer for sale, the company will not receive any of the proceeds.

The company makes Class III and Class C and D medical devices, mainly for vascular and structural heart intervention. The anchor book was scheduled for 14 October, and the shares are proposed to be listed on BSE and NSE. The upper band values the company at about Rs 3,497 crore.

Click Here – Get Free Investment Predictions

Table of Contents

Sahajanand Medical Technologies IPO Details

The table below sets out the key parameters of the Sahajanand Medical Technologies IPO, including the price band, lot size and important dates.

Open Date	15 October 2026
Close Date	19 October 2026
Face Value	Re 1 per share
Price Band	Rs 327 to Rs 344 per share
Lot Size	43 shares
Issue Size	Rs 475.48 crore (entirely offer for sale)
Issue Type	Book Built Issue, Mainboard
Listing At	BSE, NSE
Allotment Date	21 October 2026
Listing Date	23 October 2026

Sahajanand Medical Technologies IPO Quick Facts

Particulars	Snapshot
Minimum retail investment	Rs 14,792 (1 lot, 43 shares, at the upper band)
Retail maximum	13 lots, 559 shares (Rs 1,92,296)
Promoter holding	40.82 percent before the issue, 36.20 percent after
Valuation at upper band	About Rs 3,497 crore
Registrar	MUFG Intime India Pvt Ltd
Lead Managers	Motilal Oswal Investment Advisors, Avendus Capital, HSBC Securities, Nuvama Wealth Management

This snapshot is meant as a quick reference alongside the fuller details table above, so investors scanning the Sahajanand Medical Technologies IPO on mobile can find the essentials without scrolling through the whole page.

Sahajanand Medical Technologies IPO Share Reservation

The issue offers 50 percent of the offer to qualified institutional buyers, 15 percent to non-institutional investors and 35 percent to retail investors. The anchor book opened on 14 October ahead of public bidding.

Sahajanand Medical Technologies IPO Subscription Status Day 1

Bidding for the issue has opened today, 15 October 2026, so the category wise numbers below will fill in as the session progresses. Larger institutional bids in mainboard issues often arrive late in the window, so Day 1 numbers usually lean on retail.

Investor Category	Subscription Status, Day 1 (15 Oct)
Qualified Institutional Buyers (QIB)	Bidding just opened, updating through the session
Non-Institutional Investors (NII)	Bidding just opened, updating through the session
Retail Individual Investors	Bidding just opened, updating through the session
Overall	Bidding just opened, updating through the session

Track Subscription Status for the issue on the Univest Screener

How to Apply for the Sahajanand Medical Technologies IPO

Open a Demat and trading account with a SEBI-registered broker such as Univest if you do not already have one.
Select the issue on your broker app or net banking platform and enter your bid quantity and price within the Rs 327 to Rs 344 band, in multiples of 43 shares.
Submit the application through the UPI-based ASBA method so the bid amount is blocked rather than debited immediately.
Approve the UPI mandate on your phone before the daily cut off time, and remember the issue closes on 19 October.

Download the Univest iOS App or Univest Android App to apply for the issue on its opening day.

Grey market premium (GMP) is an unofficial, unregulated indicator for the issue that is not endorsed by SEBI, NSE, or BSE. Investors looking for indicative GMP data can go through other relevant sources, though such figures should never be the sole basis for an investment decision.

About Sahajanand Medical Technologies Limited

Sahajanand Medical Technologies Limited, incorporated in 2001 and based in Surat, makes medical devices focused on vascular and structural heart intervention. Total income was Rs 908.59 crore in FY24, Rs 1,035.96 crore in FY25 and Rs 1,218.73 crore in FY26, while profit after tax moved from a loss of Rs 7.35 crore to Rs 25.15 crore and Rs 69.08 crore. For the quarter ended June 2026, total income was Rs 354.33 crore and profit after tax Rs 15.09 crore. Promoters hold 40.82 percent before the issue and 36.20 percent after it.

Conclusion

The issue has opened for bidding today, 15 October 2026, offering exposure to a medical devices maker that has turned profitable through a pure offer for sale. Investors considering the issue should weigh the valuation against listed peers such as Poly Medicure and the pricing pressure on stents, and read the RHP on bseindia.com before applying after independent due diligence.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

FAQs

What is the Sahajanand Medical Technologies IPO subscription status on Day 1?

Ans. The issue opened for bidding today, 15 October 2026, so Day 1 category wise figures are still filling in through the trading session. Investors can track the live numbers on BSE and NSE as the day progresses.

When does the Sahajanand Medical Technologies IPO open and close?

Ans. The issue opened for subscription today, 15 October 2026, and will close on 19 October 2026.

What is the Sahajanand Medical Technologies IPO price band and lot size?

Ans. The issue price band is Rs 327 to Rs 344 per share, with a lot size of 43 shares. A retail investor needs at least one lot, which is about Rs 14,792 at the upper price band.

What is the issue size and structure of the Sahajanand Medical Technologies IPO?

Ans. The issue is entirely an offer for sale of up to 1,38,22,116 equity shares worth about Rs 475.48 crore, with no fresh issue component, so the company does not receive proceeds.

What is the Sahajanand Medical Technologies IPO GMP?

Ans. Grey market premium (GMP) is an unofficial, unregulated indicator for the issue that is not endorsed by SEBI, NSE, or BSE. Investors looking for indicative GMP data can go through other relevant sources, though such figures should never be the sole basis for an investment decision, especially this early in the bidding window.

How do I apply for the Sahajanand Medical Technologies IPO?

Ans. You can apply for the issue through your SEBI-registered broker or UPI-enabled banking app using the ASBA method, enter your bid quantity and price within the Rs 327 to Rs 344 band, in multiples of 43 shares, then approving the UPI mandate before the daily cut off.

When will the Sahajanand Medical Technologies IPO be allotted and listed?

Ans. The issue allotment is expected to be finalised on 21 October 2026, and the shares are tentatively scheduled to list on BSE and NSE on 23 October 2026.

What does Sahajanand Medical Technologies Limited do?

Ans. Sahajanand Medical Technologies Limited makes Class III and Class C and D medical devices, mainly for vascular and structural heart intervention, and is based in Surat.

How is the Sahajanand Medical Technologies IPO split among investors?

Ans. The issue offers 50 percent to qualified institutional buyers, 15 percent to non-institutional investors and 35 percent to retail investors.

Who are the registrar and lead manager for the Sahajanand Medical Technologies IPO?

Ans. MUFG Intime India Pvt Ltd is the registrar for the issue, and Motilal Oswal Investment Advisors, Avendus Capital, HSBC Securities and Nuvama Wealth Management are the book running lead managers.